Actualités Santen Pharmaceutical Company (PK) - SNPHY | Actions OTCMarkets

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

333-186313 SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Securities Registration (ads, Immediate) (f-6ef)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

333-186313 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

As filed with the Securities and Exchange Commission on March 30, 2015 Registration No. 333-169312 SECURITIES AND...

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

As filed with the Securities and Exchange Commission on March...

Securities Registration (ads, Immediate) (f-6ef)

As filed with the Securities and Exchange Commission on October 16, 2014 Registration No. [___]-[___] ...

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in C...

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian...

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology PR Newswire SAN DIEGO and OSAKA, Japan...

Securities Registration (ads, Immediate) (f-6ef)

As filed with the Securities and...

Securities Registration (ads, Immediate) (f-6ef)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Santen Pharmaceutical Company (PK) (SNPHY)

Outils de qualité professionnelle, pour des investisseurs individuels.

SNPHY Actualités

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Securities Registration (ads, Immediate) (f-6ef)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Securities Registration (ads, Immediate) (f-6ef)

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in C...

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology

Securities Registration (ads, Immediate) (f-6ef)

Securities Registration (ads, Immediate) (f-6ef)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Santen Pharmaceutical Company (PK) (SNPHY) Actualités

Santen Pharmaceutical Company (PK) (SNPHY)

Outils de qualité professionnelle, pour des investisseurs individuels.

SNPHY Actualités

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Securities Registration (ads, Immediate) (f-6ef)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)

Securities Registration (ads, Immediate) (f-6ef)

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in C...

Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology

Securities Registration (ads, Immediate) (f-6ef)

Securities Registration (ads, Immediate) (f-6ef)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application